DNTH Dianthus Therapeutics
- 24.445
- +0.635+2.67%
Dianthus Therapeutics News
Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%), etc.
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(5.1%),TCG Crossover Fund II, L.P.(5.1%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.9%),VHCP Co-Investment Holdings III, LLC(5.9%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-5AM Ventures VII, L.P.(3.5%),5AM Partners VII, LLC(3.5%), etc.
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | 10-Q: Q3 2024 Earnings Report
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Dianthus Therapeutics | RW: Registration Withdrawal Request
Dianthus Therapeutics | 424B5: Prospectus
Dianthus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Octagon Capital Advisors LP(6.0%),Ting Jia(6.0%), etc.
Dianthus Therapeutics | 424B3: Prospectus
Dianthus Therapeutics | EFFECT: Others
Dianthus Therapeutics | EFFECT: Others
Dianthus Therapeutics | CORRESP: CORRESP
Dianthus Therapeutics | CORRESP: CORRESP
Dianthus Therapeutics | UPLOAD: Others
Dianthus Therapeutics | UPLOAD: Others
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
No Data